Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFOTAXIME

CEFOTAXIME SODIUM

Standard Dose
EQ 20GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CEFOTAXIME is listed in Drugs@FDA under application 064201 (ANDA).

Marketing status: Discontinued Active ingredient CEFOTAXIME SODIUM Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2008-04-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFOTAXIME is listed in Drugs@FDA under application 064201 (ANDA). Marketing status: Discontinued Active ingredient CEFOTAXIME SODIUM Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2008-04-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CEFOTAXIME (CEFOTAXIME SODIUM) | Drug Monograph | MedicHelpline